首页> 外文期刊>Acta Virologica: International Journal >Virus neutralization study using H120, H52, 793/B antisera against Iranian infectious bronchitis virus genotypes
【24h】

Virus neutralization study using H120, H52, 793/B antisera against Iranian infectious bronchitis virus genotypes

机译:病毒中和研究使用H120,H52,793 / B抗血清对伊朗传染性支气管炎病毒基因型进行抗血清

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious bronchitis virus (IBV), a major pathogen of the domestic fowl, exhibits extensive antigenic variation. IBV is a member of the Coronaviridae family and the genus Gammacoronavirus. A new infectious bronchitis virus serotype can emerge from only very few amino acid changes within the major peplomer glycoprotein, namely in its S1 part forming the virion spike. Principally, the serotypes are identified by virus neutralization (VN) tests. This study is aimed to investigate the neutralizing efficiency of H52, H120, and 4/91 antiserum against IBV genotypes (IS-1494, IS-720, 793/B, IR-I) recently circulating in Iran. For the first time, we have used cross-neutralization tests for the serological classification of these isolates. In this study, all antisera failed to neutralize all IBV strains. According to the results of our research, cross-protection studies are necessary for the design of a proper vaccination program for IBV circulating genotypes in Iran. The data are useful for the development of new vaccine strategies.
机译:感染性支气管炎病毒(IBV)是国产家禽的主要病原体,表现出广泛的抗原变异。 IBV是Coronaviridae家族和Gammacoronavirus属的成员。一种新的传染性支气管炎病毒血清型可以从主要的Peplomer糖蛋白内的非常少量的氨基酸变化中出现,即在其S1部件形成病毒虫峰值中。主要是,通过病毒中和测试鉴定血清型(VN)测试。本研究旨在研究H52,H120和4/91抗血管对抗IBV基因型的中和效率(IS-1494,IS-720,793 / B,IR-1)最近在伊朗循环。我们首次使用了对这些分离株的血清学分类的交叉中和测试。在这项研究中,所有抗血清都未能中和所有IBV菌株。根据我们的研究结果,对伊朗IBV循环基因型的适当疫苗接种计划设计有关交叉保护研究。这些数据对于开发新的疫苗策略是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号